Home » Topics » Regulatory

Regulatory
RSS

Effexor XR approved for adults with panic disorder

Nov. 22, 2005

BioMimetic's GEM-21S approved for periodontal bone defects

Nov. 22, 2005

Shanghai Sunway Biotech's H101 approved for refractory nasopharyngeal cancer

Nov. 18, 2005

Procoralan receives European approval for chronic stable angina

Nov. 16, 2005

FDA approves new indication for Invanz

Nov. 16, 2005

FDA approves intravenous administration of Oncaspar

Nov. 14, 2005

Tarceva approved in combination with gemcitabine for pancreatic cancer

Nov. 3, 2005

First worldwide approval for Exjade in U.S.

Nov. 3, 2005

Noxafil approved in E.U. for invasive fungal infections

Oct. 28, 2005

Ebixa receives European approval for moderate Alzheimer's disease

Oct. 14, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.